We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
45.50 | 3.35% | 1,402.00 | 1,401.50 | 1,402.50 | 1,403.50 | 1,365.00 | 1,365.00 | 9,366,211 | 16:29:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.79 | 56.23B |
TIDMGSK
RNS Number : 6209H
GlaxoSmithKline PLC
05 August 2021
GlaxoSmithKline plc
Block listing Application
Application has been made to the Financial Conduct Authority and the London Stock Exchange plc for a total of 3,230,000 Ordinary Shares of 25p each ('Shares') to be admitted to the Official List.
The Shares are being reserved under an existing block listing and will be issued under the GlaxoSmithKline plc Share Save Plan 2012 and GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan.
When issued, the Shares will rank pari passu with the existing Ordinary Shares of 25p each.
Admission is expected to be effective on 6 August 2021.
V A Whyte
Company Secretary
5 August 2021
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ALSFLFIDTSISIIL
(END) Dow Jones Newswires
August 05, 2021 04:00 ET (08:00 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions